Advertisement
This evolving technology presents both opportunities and challenges
By Robert J. Noecker, MD, MBA
Detection of progressive RNFL thinning with GPA/TPA aids in management & treatment decisions
By Christopher Leung, MD
Poor patient compliance and inadequate control of IOP impede successful treatment
By Eydie Miller-Ellis, MD,
Results from the EAGLE trial provide key insights into the treatment of glaucoma
By Shan C. Lin, MD, Sunee Chansangpetch, MD
Q&A with Aerie Pharmaceuticals CMO Rick Lewis
By ERIN MURPHY, CONTRIBUTING
Alcon is the first company to deploy an MSL team in the field of ophthalmic surgery
By Arthur Chan, PhD, MBA
How and when to code for these procedures
By Kevin J. Corcoran, COE, CPC, CPMA, FNAO